Tamoxifen bound ERα predominantly recruits coactivator proteins in endometrial cells, but recruits corepressor proteins in breast cancer cells; these different coregulator recruitment profiles enable tamoxifen to stimulate or inhibit transcription in the two cell types [17]. The gene discussed is ESR1; the disease is breast cancer.